Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
sepsis (E Coli); IGA Nephropathy; had 3 UTI's; This is a spontaneous report received from a Consumer or other non HCP. A 51-year-old female patient received BNT162b2 (BNT162B2), on 03Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 48 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Allergy to tree nuts" (unspecified if ongoing). There were no concomitant medications. No other vaccine on the same date. Vaccination history included: Covid-19 (DOSE 1, SINGLE; Manufacturer unknown), for COVID-19 immunization. The following information was reported: IGA NEPHROPATHY (medically significant) with onset 04Dec2023, outcome "recovered with sequelae"; URINARY TRACT INFECTION (medically significant) with onset 04Dec2023, outcome "recovered with sequelae", described as "had 3 UTI's"; ESCHERICHIA SEPSIS (hospitalization) with onset 04Dec2023, outcome "recovered with sequelae", described as "sepsis (E Coli)". The patient was hospitalized for escherichia sepsis (hospitalization duration: 4 day(s)). Clinical course: Prior to this vaccine patient never had an kidney issues or UTI's in her life. Now in 2023 she had 3 UTI's. 2 that she been hospitalized for sepsis (e Coli). And also have been diagnosed with IGA nephropathy. Patient truly believed all this issues were from the vaccine, now she had to live with this the rest of her life. Therapeutic measures were not taken as a result of escherichia sepsis, iga nephropathy, urinary tract infection. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Allergy to nuts